CURLO, Margherita
 Distribuzione geografica
Continente #
NA - Nord America 695
EU - Europa 412
AS - Asia 392
AF - Africa 24
Continente sconosciuto - Info sul continente non disponibili 5
Totale 1.528
Nazione #
US - Stati Uniti d'America 688
CN - Cina 292
SE - Svezia 192
IE - Irlanda 151
TR - Turchia 46
SG - Singapore 33
CI - Costa d'Avorio 23
FI - Finlandia 19
DE - Germania 15
IT - Italia 12
IR - Iran 11
IN - India 9
CA - Canada 7
BE - Belgio 5
EU - Europa 5
RO - Romania 4
FR - Francia 3
ES - Italia 2
NL - Olanda 2
CZ - Repubblica Ceca 1
GB - Regno Unito 1
HU - Ungheria 1
JP - Giappone 1
MD - Moldavia 1
RU - Federazione Russa 1
SK - Slovacchia (Repubblica Slovacca) 1
UA - Ucraina 1
ZA - Sudafrica 1
Totale 1.528
Città #
Chandler 267
Dublin 151
Nanjing 62
Ashburn 59
Dearborn 55
Shanghai 50
Beijing 43
Izmir 37
Princeton 27
Abidjan 23
Helsinki 17
Nanchang 17
Shenyang 16
Singapore 14
Wilmington 13
Hebei 12
Ann Arbor 10
San Mateo 10
Tianjin 10
Kocaeli 9
Los Angeles 9
Jiaxing 8
Jinan 8
Kunming 8
New York 8
Hefei 7
Pune 7
Changsha 6
Dallas 6
Guangzhou 6
Brussels 5
Hangzhou 5
Washington 5
Zanjan 5
Andover 4
Cambridge 4
Chengdu 4
Leawood 4
Leipzig 4
Sacramento 4
Timisoara 4
Toronto 4
Bremen 3
Grafing 3
Houston 3
Ningbo 3
Norwalk 3
Wuhan 3
Zhengzhou 3
Changchun 2
Clifton 2
Huzhou 2
Magdeburg 2
Osimo 2
Parma 2
Port de Sagunt 2
Seattle 2
Taizhou 2
Augusta 1
Bangalore 1
Borås 1
Bratislava 1
Budapest 1
Chisinau 1
Cormeilles-en-Parisis 1
Edinburgh 1
Florence 1
Fremont 1
Fuzhou 1
Geislingen an der Steige 1
Haikou 1
Harbin 1
Johannesburg 1
Kashan 1
Miami 1
Moscow 1
Mountain View 1
New Delhi 1
Olomouc 1
Orange 1
Phoenix 1
Quzhou 1
Redmond 1
Rockville 1
Shaoxing 1
Stockholm 1
Tokyo 1
Trumbull 1
Vancouver 1
Winnipeg 1
Totale 1.098
Nome #
710 Gastrin-17 (G-17): A Serological Bio-Marker for Diagnosis of Gastro-Esophageal Reflux Disease (GERD) 73
W1079 Curcumin Vs Domperidon in Functional Dyspepsia: Better the Prokinetic or An Agonist of Vanilloid Receptor? 70
INFLUENCE OF BMI ON GASTRIC ACID SECRETION IN ACID RELATED DISEASE 67
P.1.193: MESALAMINE FOR THE MANAGEMENT OF PATIENTS WITH UNCOMPLICATED DIVERTICULAR DISEASE (SUDD): A 24 MONTHS PROSPECTIVE FOLLOW-UP STUDY 66
Efficacy of 5-ASA in the treatment of colonic diverticular disease 66
S1921 “GastroPanel Test” in the Clinical Outcome of GERD 65
T1082 Eradication Rate of Helicobacter pylori in Immigrant Patients Compared to Italian Patients: Results of a Clinical Trial 63
OC1.09.3 USEFULNESS OF GASTROPANEL FOR SCREENING OF ATROPHIC GASTRITIS IN PATIENTS WITH AUTOIMMUNE THYROID DISEASES 62
P.29 USEFULNESS OF NON INVASIVE TEST (GASTROPANEL) FOR SCREENING OF ATROPHIC GASTRITIS IN PATIENTS WITH AUTOIMMUNE THYROID DISEASE 62
T1651 The Natural History of Gastric Ulcer: A Twenty-Four Years Clinical-Endoscopical Follow-Up 60
M1261 Recurrence of Diverticulitis in Patients With Symptomatic Uncomplicated Diverticular Disease (SUDD) Treated Cyclically With Mesalamine: Result of a Follow-up Study 59
W1235 Efficacy of 5-ASA in the Treatment of Colonic Diverticular Disease: A Systematic Review 58
PA.27 GASTRO PANEL® FOR DETECTION OF ATROPHIC GASTRITIS: THE “PARMA MODEL” 58
T1979 Pepsinogen II As Marker of Inflammation in H.P Infection and in NSAIDs Damage 57
M1260 Effect of Cyclically Long-Term Treatment With Mesalamine in Patients With Symptomatic Uncomplicated Diverticular Disease (SUDD): A 5 Years Follow-up Study 56
OC3.07.1 CURCUMIN VS DOMPERIDON IN FUNCTIONAL DYSPEPSIA: BETTER THE PROKINETIC OR AN AGONIST OF VANILLOID RECEPTOR? 56
PA.6 GASTRIN-17 (G-17): A SEROLOGICAL BIO-MARKER FOR DIAGNOSIS OF GASTRO-ESOPHAGEAL REFLUX DISEASE (GERD) 56
PA.28 SERUM PEPSINOGEN I AS NON INVASIVE MARKER OF GASTRIC ACID SECRETION 55
PA.61 DIVERTICULAR DISEASE OF THE COLON IN PARMA AREA: THE EPIDEMIOLOGY IN A PRIMARY CARE SETTING 52
CS1.1 EFFICACY OF MESALAMINE AND THE ASSOCIATION OF MESALAMINE AND PROBIOTICS VERSUS RIFAXIMIN IN THE TREATMENT OF SYMPTOMATIC DIVERTICULAR DISEASE 52
M1262 Baseline Symptoms in Patients With Symptomatic Uncomplicated Diverticular Disease (SUDD) 52
“GASTROPANEL TEST” IN THE CLINICAL OUTCOME OF GERD 51
Pepsinogen I, II, Ratio, and G-17 in Patients With Esophagitis and Patients With Extra-Esophageal Manifestations of GERD 51
PA.7 CLINICAL VARIABILITY IN THE PRESENTATION OF THE GASTROESOPHAGEAL REFLUX DISEASE BEFORE THE HP ERA (STUDY FROM 1975 TO 1995) 49
PO.1 NERD AND ERD: THE SCENARIO IS CHANGING OVER THE TIME? A 30 YEARS FOLLOW UP STUDY 49
P.1.292: SYMPTOMATOLOGICAL PATTERN IN PATIENTS WITH SYMPTOMATIC UNCOMPLICATED DIVERTICULAR DISEASE (SUDD), IRRITABLE BOWEL SYNDROME-DIARRHOEA (IBS-D), AND IBS-D PLUS SUDD 49
LONG-TERM TREATMENT WITH MESALAMINE IN DIVERTICULAR DISEASE: A FIVE YEARS FOLLOW-UP STUDY 42
Totale 1.556
Categoria #
all - tutte 6.141
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.141


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020168 0 43 3 1 8 43 23 10 11 14 10 2
2020/202117 0 0 4 0 0 0 0 0 2 9 2 0
2021/2022177 0 0 0 17 21 5 3 8 6 16 35 66
2022/2023694 64 89 62 77 41 82 6 58 187 3 22 3
2023/2024220 7 23 11 6 15 49 22 19 11 10 22 25
2024/202544 37 7 0 0 0 0 0 0 0 0 0 0
Totale 1.556